REFERENCE
European Medicines Agency.CHMP post-authorisation summary of positive opinion for Eliquis. Internet Document: 21 Sep 2012. Available from: URL: http://www.ema.europa.eu
Rights and permissions
About this article
Cite this article
The European CHMP has adopted a new indication for apixaban [Eliquis] 2.5 mg and 5 mg. React. Wkly. 1423, 3 (2012). https://doi.org/10.2165/00128415-201214230-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201214230-00007